Anew Medical (WENA) Stock Analysis
NASDAQHealthcareBiotechnology
What Anew Medical does
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Key metrics
ETFs linked to WENA
Broad-market and Healthcare sector ETFs an investor holding Anew Medical is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how WENA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze WENA in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Anew Medical?
- Anew Medical trades under the ticker WENA on NASDAQ.
- Which exchange is WENA listed on?
- WENA is listed on NASDAQ.
- What sector does Anew Medical operate in?
- Anew Medical is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze WENA in a portfolio?
- PortView shows WENA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.